PT. Mandom Indonesia Tbk (TCID) Fair Value & Analysis
Consumer Defensive · ID · Market cap 1.1T IDR
Fair value as of: Jun 24, 2026
Analysis
PT. Mandom Indonesia Tbk (TCID) currently trades at 2,770 IDR, while our model-based Fair Value estimate is 798.98 IDR — implying the stock looks roughly 71.2% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
PT. Mandom Indonesia Tbk manufactures and sells cosmetics and other products in Indonesia. It offers hair care, skin care and make-up, body care, and face care products, as well as perfumes, cleansing materials, and plastic containers. The company markets its products under the GATSBY, PIXY, PUCELLE, MIRATONE, LUCIDO-L, MANDOM, Tancho, JOHNNY ANDREAN, SPALDING, GLAZELLE de Pucelle, Color Comm., Fresh n fresh, LOVILLEA, and STYLE UP brands. It sells its products in the United Arab Emirates, Malaysia, Japan, Thailand, the Philippines, Singapore, Korea, Vietnam, Hongkong, India, and Taiwan. The company was formerly known as PT Tancho Indonesia and changed its name to PT. Mandom Indonesia Tbk in 2001. The company was incorporated in 1969 and is headquartered in Jakarta, Indonesia. PT. Mandom Indonesia Tbk operates as a subsidiary of Mandom Corporation.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is PT. Mandom Indonesia Tbk (TCID) undervalued?
What is the fair value of TCID?
What is the quality score of TCID?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.